Skip to main content

Table 2 Mortality results following experimental challenges with 4 RHDV2 or 1 RHDV reference strains.

From: Emergence of a new lagovirus related to Rabbit Haemorrhagic Disease Virus

Study Rabbit origin Administration route Inoculum strain Mortality Seropositivity of the survivors (doubtful)2 Mortality 2nd challenge RHDV BS89
A 1 NZ IM 10-07 1/5 /  
  V/RHD/4 3/5 /  
B 1 NZ oral 10-28 6/8 /  
C NZ IM 10-28 1/2 1/1  
  oral 10-28 2/2 /  
D NZ oral 10-28 3/9 6/6  
E NZ oral 10-28 0/5 5/5  
F NZ oral Ud11 1/5 4/4 0/43
G 1 NZ oral 10-32 0/8 /  
  V/RHD/4 8/8 /  
H NZ oral 10-32 0/3 3/3  
I NZ IV 10-32 0/4 4/4 0/13
  oral 10-32 1/6 5/5 2/43
J NZ oral 10-32 2/5 3/3  
K NZ oral 10-32 0/5 4(1)/5  
L NZ oral 10-32 0/5 5/5 0/43
  Rural oral 10-32 0/5 5/5 1/5
  1. The experimental challenges were performed with RHDV2 strains 10–07, 10–28, 10–32, and Ud11, or with the French RHDV reference strain V/RHD/4, using different inoculation routes. For experiments F, I, and L, mortality results following a second challenge with the Italian RHDV reference strain BS89 of the survivor rabbits are shown.
  2. NZ New Zealand, IM intramuscularly route, IV intravenous route.
  3. 1no serological data.
  4. 2doubtful because just above the threshold.
  5. 3the 2nd challenge was performed on a part of the survivor rabbits.